Cargando…

Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts

We report longitudinal diffusion-weighted magnetic resonance imaging (DW-MRI) and dynamic contrast enhanced (DCE)-MRI (7 T) studies designed to identify functional changes, prior to volume changes, in trastuzumab-sensitive and resistant HER2 + breast cancer xenografts. Athymic mice (N = 33) were sub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whisenant, Jennifer G., Sorace, Anna G., McIntyre, J. Oliver, Kang, Hakmook, Sánchez, Violeta, Loveless, Mary E., Yankeelov, Thomas E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311041/ https://www.ncbi.nlm.nih.gov/pubmed/25500087 http://dx.doi.org/10.1016/j.tranon.2014.09.011

Ejemplares similares

Breast MR with special focus on DW-MRI and DCE-MRI
por: Petralia, G., et al.
Publicado: (2011)

Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion Classification
por: Fusco, Roberta, et al.
Publicado: (2015)

Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer
por: Syed, Anum K., et al.
Publicado: (2018)

DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic
por: Winfield, Jessica M., et al.
Publicado: (2016)

Characterizing Errors in Pharmacokinetic Parameters from Analyzing Quantitative Abbreviated DCE-MRI Data in Breast Cancer
por: Slavkova, Kalina P., et al.
Publicado: (2021)

Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's Disease
por: Zhu, Jianguo, et al.
Publicado: (2016)

CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro
por: Song, Patrick N., et al.
Publicado: (2020)

Multiparametric Analysis of Longitudinal Quantitative MRI Data to Identify Distinct Tumor Habitats in Preclinical Models of Breast Cancer
por: Syed, Anum K., et al.
Publicado: (2020)

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report
por: Petrillo, Mario, et al.
Publicado: (2015)

Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation
por: Barnes, Stephanie L., et al.
Publicado: (2012)

DW-MRI of the urogenital tract: applications in oncology
por: Petralia, G., et al.
Publicado: (2010)

DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts
por: Hompland, Tord, et al.
Publicado: (2014)

Towards integration of (64)Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer
por: Jarrett, Angela M., et al.
Publicado: (2020)

DW-MRI of the breast: a pictorial review
por: Durur-Subasi, Irmak
Publicado: (2019)

Quantifying Tumor Heterogeneity via MRI Habitats to Characterize Microenvironmental Alterations in HER2+ Breast Cancer
por: Kazerouni, Anum S., et al.
Publicado: (2022)

DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment
por: Hauge, Anette, et al.
Publicado: (2017)

The Potential Use of DCE-MRI Texture Analysis to Predict HER2 2+ Status
por: Jiang, Zejun, et al.
Publicado: (2019)

DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
por: Wegner, Catherine S., et al.
Publicado: (2018)

Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
por: Virostko, John, et al.
Publicado: (2021)

Comparison of Ultrafast Dynamic Contrast-Enhanced (DCE) MRI with Conventional DCE MRI in the Morphological Assessment of Malignant Breast Lesions
por: Ohashi, Akane, et al.
Publicado: (2023)

Assessing Treatment Response Through Generalized Pharmacokinetic Modeling of DCE-MRI Data
por: Kontopodis, Eleftherios, et al.
Publicado: (2015)

DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response
por: Thibault, Guillaume, et al.
Publicado: (2017)

Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: Comparison with conventional DCE-MRI
por: Zhang, Jin, et al.
Publicado: (2020)

Assessment of cardiac RF ablation lesions by DCE-MRI
por: Vijayakumar, Sathya, et al.
Publicado: (2014)

DCE-MRI of Tumor Hypoxia and Hypoxia-Associated Aggressiveness
por: Gaustad, Jon-Vidar, et al.
Publicado: (2020)

Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status
por: Lu, Hecheng, et al.
Publicado: (2020)

Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy()()
por: Yip, Connie, et al.
Publicado: (2017)

The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
por: Lu, Yanan, et al.
Publicado: (2019)

DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
por: Qu, Jinrong, et al.
Publicado: (2022)

Correlations of 3T DCE-MRI Quantitative Parameters with Microvessel Density in a Human-Colorectal-Cancer Xenograft Mouse Model
por: Ahn, Sung Jun, et al.
Publicado: (2011)

Modelling DW-MRI data from primary and metastatic ovarian tumours
por: Winfield, Jessica M., et al.
Publicado: (2015)

Carotid stents, stroke and DW-MRI, HOCM and alcohol ablation and more...
por: EROL, Çetin
Publicado: (2022)

Dependence of DCE-MRI biomarker values on analysis algorithm
por: Ng, Chaan S., et al.
Publicado: (2015)

Editorial: Use of DCE-MRI in female affecting cancers
por: Romeo, Valeria, et al.
Publicado: (2023)

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
por: O'Connor, J P B, et al.
Publicado: (2007)

Response Evaluation of Choroidal Melanoma After Brachytherapy Using Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI): Preliminary Findings
por: Bitencourt, Flávia B. C. S. N., et al.
Publicado: (2020)

Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI()
por: Tudorica, Alina, et al.
Publicado: (2016)

Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response()
por: Ashraf, Ahmed, et al.
Publicado: (2015)

Quantifying the Effects of Combination Trastuzumab and Radiation Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
por: Bloom, Meghan J., et al.
Publicado: (2022)

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models
por: Veeraraghavan, Jamunarani, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9rgmiju052u7q0erhmutguu58k